Patient Guide: A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 18 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05201248
Status: ACTIVE_NOT_RECRUITING
Condition: B-Cell Non-Hodgkin Lymphoma
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 18 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing, Beijing
  • Beijing, Beijing
  • Fuzhou, Fujian
  • • And 15 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily